FIDES MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FIDES MEDICAL
Largest movements
- Cash -€171,267
down €171,267 (-20.2%), from €847,870 to €676,603
mainly Net result for the year (-€106,006) and Receivables within one year (-€73,149)
- Receivables within one year +€73,149
up €73,149 (+1,360%), from €5,380 to €78,530
- Tangible fixed assets -€10,569
down €10,569 (-8.8%), from €120,688 to €110,120
of which Land and buildings: -€10,277
- Reserves -€79,132
down €79,132 (-8.6%), from €922,350 to €843,218
of which Distributable reserves: -€79,132
- Profit (loss) carried forward -€26,874
no longer reported in 2025 (was €26,874)
- Taxes -€16,273
down €16,273 (-89.1%), from €18,256 to €1,983
- Gross operating margin -€11,246
down €11,246 (-12.1%), from -€92,631 to -€103,877
- Depreciation -€2,246
down €2,246 (-17.5%), from €12,814 to €10,569
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €981,104 | €869,736 | -€111,368 | -11.4% |
| Fixed assets | 21/28 | €120,688 | €110,120 | -€10,569 | -8.8% |
| Tangible fixed assets | 22/27 | €120,688 | €110,120 | -€10,569 | -8.8% |
| Land and buildings | 22 | €120,337 | €110,060 | -€10,277 | -8.5% |
| Plant, machinery and equipment | 23 | €54 | - | -€54 | |
| Furniture and vehicles | 24 | €298 | €60 | -€238 | -80.0% |
| Current assets | 29/58 | €860,416 | €759,616 | -€100,799 | -11.7% |
| Amounts receivable within one year | 40/41 | €5,380 | €78,530 | +€73,149 | +1,360% |
| Other amounts receivable | 41 | €5,380 | €78,530 | +€73,149 | +1,360% |
| Cash at bank and in hand | 54/58 | €847,870 | €676,603 | -€171,267 | -20.2% |
| Deferred charges and accrued income | 490/1 | €7,166 | €4,484 | -€2,682 | -37.4% |
| Total equity and liabilities | 10/49 | €981,104 | €869,736 | -€111,368 | -11.4% |
| Equity | 10/15 | €967,824 | €861,818 | -€106,006 | -11.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €922,350 | €843,218 | -€79,132 | -8.6% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €920,490 | €841,358 | -€79,132 | -8.6% |
| Profit (loss) carried forward | 14 | €26,874 | - | -€26,874 | |
| Amounts payable | 17/49 | €13,280 | €7,918 | -€5,362 | -40.4% |
| Amounts payable within one year | 42/48 | €12,119 | €4,875 | -€7,244 | -59.8% |
| Trade debts | 44 | €49 | - | -€49 | |
| Suppliers | 440/4 | €49 | - | -€49 | |
| Taxes, remuneration and social security | 45 | €12,071 | €4,875 | -€7,196 | -59.6% |
| Remuneration and social security | 454/9 | €12,071 | €4,875 | -€7,196 | -59.6% |
| Accrued charges and deferred income | 492/3 | €1,160 | €3,043 | +€1,882 | +162% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,814 | €10,569 | -€2,246 | -17.5% |
| Other operating charges | 640/8 | €4,704 | €4,448 | -€256 | -5.4% |
| Gross operating margin | 9900 | -€92,631 | -€103,877 | -€11,246 | -12.1% |
| Operating profit (loss) | 9901 | -€110,149 | -€118,894 | -€8,744 | -7.9% |
| Financial income | 75/76B | €15,039 | €15,047 | +€8 | +0.1% |
| Recurring financial income | 75 | €14,203 | €14,701 | +€498 | +3.5% |
| Non-recurring financial income | 76B | €836 | €346 | -€490 | -58.7% |
| Financial charges | 65/66B | €193 | €175 | -€18 | -9.1% |
| Recurring financial charges | 65 | €193 | €175 | -€18 | -9.1% |
| Profit (loss) for the period before taxes | 9903 | -€95,303 | -€104,022 | -€8,719 | -9.1% |
| Income taxes | 67/77 | €18,256 | €1,983 | -€16,273 | -89.1% |
| Profit (loss) for the period | 9904 | -€113,560 | -€106,006 | +€7,554 | +6.7% |
| Transfer from tax-exempt reserves | 789 | €89,916 | - | -€89,916 | |
| Profit (loss) for the period to be appropriated | 9905 | -€23,644 | -€106,006 | -€82,362 | -348% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.